U.S. Markets closed

Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years

ALLISON GATLIN
Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years

Dow Jones component Pfizer could become a leader in colon cancer treatment with its looming $11.4 billion acquisition of biotech company Array BioPharma, an analyst said Wednesday.